 The KN-8701 trial is a multi-center, open-label, two-part trial of Kinnates lead RAF inhibitor candidate KIN-2787 The KN-8701 trial is a multi-center, open-label, two-part trial of Kinnates lead RAF inhibitor candidate KIN-2787 